[18,19] Impaired GLP-1 secretion and signaling is a huge problem for anyone , but particularly a diabetic
This area allows for a slower absorption rate compared to the abdomen, which may help reduce side effects for some users
It binds to GLP-1 receptors, enhancing insulin secretion, reducing glucagon production, and slowing digestion
[2] For instance, antimicrobial peptides such as LL-37 can inhibit the growth of harmful pathogens while supporting the survival of beneficial commensal bacteria, helping to preserve microbial diversity
Your body adapts
Bunce and his team found that, after three weeks, the GLP-1 agonist group reported a 40% reduction in cravings compared with the standard care-only group